6/26/2023 0 Comments In accordance with crosswordArticle contentĬAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS:Ĭertain information in this news release may contain forward-looking information within the meaning of applicable securities laws. For more information about the Company, visit This advertisement has not loaded yet, but your article continues below. The Company’s flagship product QuickStrip™ is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals and vaccines, that are delivered quickly into the bloodstream, resulting in rapid onset of the active ingredient. Rapid Dose Therapeutics is a Canadian biotechnology company revolutionizing drug delivery through innovation. In accordance with NI 51-102, the Company’s notice of change of auditor, together with the required letters from the Former Auditor and the Successor Auditor, have been filed on SEDAR.Ībout Rapid Dose Therapeutics Corp. ![]() There are no “reportable events” (as the term is defined in National Instrument 51-102: Continuous Disclosure Obligations (“ NI 51-102”)) between the Company and the Former Auditor. There were no modified opinions in the Former Auditor’s audit reports for the Company’s two most recent financial years and ending at the date of the resignation of the Former Auditor. This advertisement has not loaded yet, but your article continues below.
0 Comments
Leave a Reply. |